Target intelligence / Profile preview

Tectonic family member 2 (TCTN2)

Target
TCTN2
Molecular classification
Other (type I transmembrane protein, ciliary protein, tectonic family)
01

Overview

Tectonic family member 2 (TCTN2) is a type I transmembrane protein localized at the ciliary transition zone, where it forms part of a multiprotein barrier complex essential for ciliogenesis and signal transduction, specifically regulating Hedgehog and Wnt pathways[1][2]. TCTN2 is necessary for ciliary function and organ development; disruptions cause ciliopathies including Meckel syndrome type 8 and Joubert syndrome 24, characterized by developmental, neurological, and renal abnormalities[2][3]. In cancer, TCTN2 is upregulated and acts as an oncogene, promoting anchorage-independent growth, invasiveness, suppressing apoptosis, and enhancing cilia formation in various tumor types[1]. Downregulation of TCTN2 impairs cilia assembly, reduces proliferation, and sensitizes to apoptosis in cancer cells, supporting its exploration as a cancer therapeutic target and potential biomarker[1]. No direct drug modulators are currently reported; epigenetic editing of TCTN2 expression has shown therapeutic potential in preclinical studies[1].

Other names
Tectonic-2C12orf38TECT2FLJ12975MKS8JBTS24Meckel syndrome type 8
02

Biological functions

CiliogenesisCiliary transition zone barrier formationSignal transduction (notably Hedgehog signaling)
03

Disease associations

Cancer (oncogene in colorectal, lung, ovary cancers)[1]Ciliopathies (Meckel syndrome type 8, Joubert syndrome 24)[2][3]
04

Safety considerations

Mutations cause severe syndromic ciliopathies (Meckel syndrome, Joubert syndrome), implying possible developmental and neurological risks with modulation[2][3]
05

Biomarkers

Potential oncogenic biomarker in colorectal, lung, and ovary cancers[1]

Beyond the preview

Go deeper on Tectonic family member 2 (TCTN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tectonic family member 2 (TCTN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call